KKR delivered its Q4 2025 earnings call on Feb 5 with the stock at RSI 9.7 — the 10th time in 16 years public that the stock dropped >20% in a month. Scott Nuttall explicitly framed this as historically a "great entry point."

The tension: Stock pricing for deteriorating fundamentals. Call showed the opposite.

What Accelerated

Monetization pipeline: $900M+ signed/visible deals for H1 2026 monetization revenue vs ≈$400M same point last year (125%+ increase). Embedded gains hit $19B record (+19% YoY, +50% vs 2 years ago). Gross realized carry +30% YoY. Management attributes outperformance to avoiding 2021 vintage over-concentration that's constraining industry exits.

Operating leverage divergent from peers: Since end-2022, KKR grew management fees +46% vs operating expenses +21%. Rob Lewin stated three closest peers show "pretty much the inverse" — all grew expenses faster than fees, "in two of three by a pretty substantial margin." FRE margin 69% full-year. LTM FRE/share trajectory now expected to "meaningfully exceed" $4.50 target set 2+ years ago (was $2.55 LTM at time of target).

Fundraising: $129B record in 2025 (nearly 2x two years ago). Already $240B+ toward $300B 2024-2026 target (80%+), management "highly confident" to meaningfully exceed. K-Series wealth channel doubled AUM to $35B from $18B year ago. North America PE fund >$19B committed in <1 year. January 2026 K-Series ≈$1.3B (+20% YoY despite volatility).

Insurance economics understated: Q4 reported insurance operating earnings $268M, but ≈$100M in accrued investment returns not shown due to cash accounting (vs peers who mark-to-market). Annualized run-rate accrued income ≈$250M today, expected $300-350M in 2026. Management: "If we do our jobs right, that accrued income that builds and compounds will show up in cash earnings. We expect in 2027 and 2028, you're going to start to see that." Third-party IV sidecar vehicles raised $6.5B, expected to translate to $65B+ fee-paying AUM over time.

Arctos acquisition: $1.4B equity+cash for ≈$15B AUM platform (sports franchise stakes, GP solutions, future secondaries). Near-permanent capital (no fixed end date). Immediately accretive per share. Target $100B+ AUM over time. Up to $550M additional vesting equity tied to share price + operating targets. New "KKR Solutions" vertical.

What The Market Missed

Software exposure deliberately minimized: ≈7% of AUM (management's "highly inclusive definition"), well below industry average. Been selling AI-exposed assets for "several years" where AI was "threat or question mark." Recent example: OneStream sold at 30% premium, 4.5x MOIC. Tariff exposure "low single-digit percentage of portfolio." $118B dry powder positioned as multiples of any AI-exposed concern — volatility = "amazing vintage years for investments."

The $7 ANI Guidance

Q4 2025 ANI was depressed by one-time $207M carried interest clawback. Excluding this, ANI/share was $1.30/quarter and $5.05/year (vs reported $4.87). The $7 guidance implies 38% ANI growth off the $5.05 clean base.

Management maintained $7/share ANI guidance for 2026 with caveat: "If we don't hit $7, we'll earn less in 2026 but more in 2027 and beyond." The $19B embedded gains aren't going away — monetizations deferred are earnings deferred, not destroyed.

Path to $7: FRE trajectory ($4.13 → "meaningfully exceed $4.50") + insurance ($1.23/share growing) + carry pipeline ($900M+ visibility) makes the math plausible but execution-dependent.

The Sector Context

This isn't a KKR story. It's an alt AM sector dislocation.

Every major name remains deeply oversold: BX RSI 12.4, ARES 22.9, APO 37.9, CG 31.4, TPG 22.6, KKR 17.8. 1-month drawdowns range from -8% (APO) to -24% (ARES). All while reporting record/near-record operational metrics:

  • BX beat estimates by 14%, sold off
  • ARES record AUM, sold off
  • TPG beat estimates, sold off

KKR at 29.4% idiosyncratic variance means this is primarily a sector bet, not KKR-specific alpha. The cross-ticker convergence is the signal — indiscriminate selling while fundamentals accelerate.

Valuation

KKR trades at 12.78x forward ANI ($7 guidance). Historical range: 15-20x during growth periods, 10-12x during distress.

Even a bear case ($6.50 ANI if monetizations slip to 2027) → 15.9x P/ANI is historically cheap for a compounder growing AUM 17%+, demonstrating divergent operating leverage, and sitting on $19B embedded gains + $118B dry powder.

Bear Case

  • Multiple compression continues (macro deteriorates, alt AM de-rates)
  • Monetizations slip to 2027 (earnings deferred, guidance miss)
  • $7 ANI depends on execution across carry pipeline, insurance accretion, FRE trajectory — ambitious
  • COO Ryan Stork departure (Jan 8, effective immediately, no successor named) — organizational gap during sector selloff

What Changed

Nothing structurally. Market repriced KKR for sector-level anxiety (tariffs, AI disruption fears, PE fundraising concerns), not company-specific deterioration. KKR showed record metrics across every forward indicator while trading at RSI 9.7.

As Nuttall noted: This is the 10th -20%+ drawdown in a month since IPO. Post-event 2-year average returns have been strong. "Market overreacts habitually to anxiety. As long as we've been public, these have been great buying opportunities."

The highest-quality name in alt AM got punished for being in alt AM.